-
Cell cycle dysregulation with overexpression of KIF2C/MCAK is a critical event in nasopharyngeal carcinoma
Author: Zuo, Xiaofeng; Meng, Peixin; Bao, Yuxin; Tao, Chuntao; Wang, Yitao; Liu, Xianjun; Bu, Youquan; Zhu, Jiang
Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 212-227. DOI: 10.1016/j.gendis.2021.05.003
-
Androgen receptor inhibits the hair follicle induction potential of dermal papilla cells by binding with Tcf4 at the A574 binding site
Author: Yu, Nanlan; Hu, Tianxing; Yang, Haichao; Zhang, Lian; Zhu, Lin; Zhou, Xiaofang; Xiang, Fei; Yang, Xichuan; Li, Yuhong
Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 51-54. DOI: 10.1016/j.gendis.2022.04.015
-
Adipose-derived stem cells and obesity: The spear and shield relationship
Author: Yang, Hong; Li, Chaowei; Li, Yizhou; Tai, Ruiqing; Sun, Chao
Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 175-186. DOI: 10.1016/j.gendis.2021.09.004
-
Dynamic m6A-ncRNAs association and their impact on cancer pathogenesis, immune regulation and therapeutic response
Author: Yan, Yuanliang; Peng, Jinwu; Liang, Qiuju; Ren, Xinxin; Cai, Yuan; Peng, Bi; Chen, Xi; Wang, Xiang; Yi, Qiaoli; Xu, Zhijie
Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 135-150. DOI: 10.1016/j.gendis.2021.10.004
-
Pathogenic roles of long noncoding RNAs in melanoma: Implications in diagnosis and therapies
Author: Xiao, Yuai; Xia, Yu; Wang, Yuchong; Xue, Chunyu
Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 113-125. DOI: 10.1016/j.gendis.2021.08.0072352-3042
-
PCK1 dysregulation in cancer: Metabolic reprogramming, oncogenic activation, and therapeutic opportunities
Author: Xiang, Jin; Wang, Kai; Tang, Ni
Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 101-112. DOI: 10.1016/j.gendis.2022.02.010
-
Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: Current status in clinical trials
Author: Song, Yanlin; Bi, Zhenfei; Liu, Yu; Qin, Furong; Wei, Yuquan; Wei, Xiawei
Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 76-88. DOI: 10.1016/j.gendis.2022.05.006
-
Liquiritigenin promotes osteogenic differentiation and prevents bone loss via inducing auto-lysosomal degradation and inhibiting apoptosis
Author: Qiu, Yu; Zhao, Yueyang; Long, Zhimin; Song, Aijia; Huang, Peng; Wang, Kejian; Xu, Ling; Molloy, David Paul; He, Guiqiong
Journal: GENES & DISEASES. 2023; Vol. 10, Issue 1, pp. 284-300. DOI: 10.1016/j.gendis.2021.06.008
